Yampolskiy categorizes self-improving software into three levels: self-modification, self-improvement, and recursive self-improvement. Self-modification primarily alters the appearance of code, while ...

Autonomous AI agents are more than just extensions of vendor tools. They’re credentialed actors who connect and execute, and ...

Hamilton, Bermuda, September 11th, 2025, ChainwireOnRe, an onchain asset manager delivering institutional-grade yield to ...

Recursion Pharmaceuticals (RXRX) closed at $4.77 in the latest trading session, marking a -1.24% move from the prior day. This change lagged the S&P 500's 0.47% gain on the day. Meanwhile, the Dow ...

Pharma layoffs in 2025 have surged, with thousands facing job cuts as companies like BMS and Novartis streamline operations.

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Seek Early Experience: Don’t wait until you feel like an expert to look for internships or entry-level roles. Getting some ...

The Busy Beaver Challenge, a notoriously difficult question in theoretical computer science, is now producing answers so ...

The traditional software development process has always been a grind: You write specs, translate them into code, debug and ...

OnRe launched OnRe Points, a rewards program designed to incentivize meaningful participation in the ONyc ecosystem.

Absci is developing ABS-101, an anti-TL1A antibody with potential in ulcerative colitis, Crohn's disease, and other ...